S&P 500 7,704.13 −0.02%
Nasdaq 26,939.37 +0.01%
S&P/TSX 35,706.46 −0.13%
Apple 335.92 −0.33%
Nvidia 224.58 −0.41%
Microsoft 497.93 −0.53%
Shopify 205.30 +2.41%
Royal Bank 282.11 +0.27%
CAD/USD 0.7068 −0.31%
CLOSED · 01:05 ET
Market ClerkRecap
Fri Sep 25 · markets closed2 signals on Sep 24167 insider buys this week · $225.2MCIRO short report next: Sep 29The week ahead
CA
INSIDER · AKTS · Aktis Oncology, Inc. · CHIEF MEDICAL OFFICER

Czibere Akos

Every open-market transaction filed under this name, Sep 23 to Sep 23.

Filings
2
0 buys · 2 sells
Bought
—
open market, at cost
Sold
$259K
includes scheduled sales
Buys since
—
no current price on file

Filings

SEC FORM 4 · OPEN MARKET
TradedTickerCompanyRoleTypeSharesPriceValueSince
Sep 23AKTSAktis Oncology, Inc.Chief Medical OfficerSell7,401$21.03$156K—
Sep 23AKTSAktis Oncology, Inc.Chief Medical OfficerSell5,099$20.19$103K—

"Since" is the stock's move from the filed price to the latest quote on file, not a scored call. Open-market purchases and sales only; option exercises and grants are excluded.